NHI's Q3 Revenue Jumps 8% Amid Aggressive Real Estate Acquisitions

TL;DR

**NHI is aggressively expanding its portfolio and boosting cash, making it a solid long-term hold in healthcare REITs.**

AI Summary

NATIONAL HEALTH INVESTORS INC (NHI) reported a robust financial performance for the nine months ended September 30, 2025, with total revenues increasing by 8.17% to $269.81 million from $249.43 million in the prior year. Net income attributable to common stockholders rose by 9.73% to $103.86 million, up from $94.65 million in the same period of 2024. Diluted earnings per share also saw an increase, reaching $2.22 compared to $2.17. The company significantly expanded its real estate portfolio, with acquisitions of real estate properties totaling $130.98 million, a substantial increase from $9.87 million in the prior year. Cash and cash equivalents surged to $81.63 million as of September 30, 2025, from $24.29 million at December 31, 2024, driven by $168.83 million in net cash provided by operating activities. Debt, net, decreased to $1.11 billion from $1.15 billion, while total assets grew to $2.69 billion from $2.61 billion. The company also issued $346.16 million in senior notes and $134.92 million in common shares, net, during the period.

Why It Matters

NHI's strong revenue and net income growth, coupled with significant real estate acquisitions, signals a confident strategic expansion in the senior housing and medical facility sectors. This aggressive investment, particularly the $130.98 million in new property acquisitions, could lead to increased future rental income and asset value for investors, potentially boosting dividend stability. For employees and customers, this expansion suggests a growing network of facilities and services, though it also implies increased operational demands. In a competitive healthcare REIT market, NHI's ability to reduce net debt while expanding its asset base positions it favorably against peers, demonstrating financial discipline alongside growth ambitions.

Risk Assessment

Risk Level: medium — The company's significant increase in acquisitions of real estate properties to $130.98 million for the nine months ended September 30, 2025, from $9.87 million in the prior year, introduces integration and market absorption risks. While debt, net, decreased to $1.11 billion from $1.15 billion, the substantial use of proceeds from revolving credit facility ($505.00 million) and senior notes ($346.16 million) for financing activities indicates reliance on debt and equity markets, which could be volatile.

Analyst Insight

Investors should consider NHI for its growth potential in the healthcare REIT sector, driven by strategic acquisitions and strong operating cash flow. Monitor the integration of new properties and the impact of rising interest rates on its debt structure, but the current financial health suggests a stable dividend payer with upside.

Financial Highlights

debt To Equity

0.74

revenue

$269.81M

operating Margin

N/A

total Assets

$2.69B

total Debt

$1.11B

net Income

$103.86M

eps

$2.22

gross Margin

N/A

cash Position

$81.63M

revenue Growth

+8.17%

Revenue Breakdown

Key Numbers

• $269.81M — Total Revenues (Increased 8.17% for the nine months ended September 30, 2025, from $249.43 million in 2024.)
• $103.86M — Net Income Attributable to Common Stockholders (Increased 9.73% for the nine months ended September 30, 2025, from $94.65 million in 2024.)
• $2.22 — Diluted Earnings Per Share (Increased from $2.17 for the nine months ended September 30, 2024, to $2.22 in 2025.)
• $130.98M — Acquisitions of Real Estate Properties (Significantly increased from $9.87 million in 2024, indicating aggressive expansion.)
• $81.63M — Cash and Cash Equivalents (Increased from $24.29 million at December 31, 2024, demonstrating strong liquidity.)
• $1.11B — Debt, Net (Decreased from $1.15 billion at December 31, 2024, improving the balance sheet.)
• $2.69B — Total Assets (Increased from $2.61 billion at December 31, 2024, reflecting portfolio growth.)
• $168.83M — Net Cash Provided by Operating Activities (Increased from $150.20 million in 2024, indicating strong operational performance.)
• $346.16M — Proceeds from Senior Notes (New financing secured during the nine months ended September 30, 2025.)
• $134.92M — Proceeds from Common Shares, Net (Equity raised during the nine months ended September 30, 2025.)

Key Players & Entities

• NATIONAL HEALTH INVESTORS INC (company) — Registrant
• SEC (regulator) — Securities and Exchange Commission
• New York Stock Exchange (regulator) — Exchange where common stock is registered
• $269.81 million (dollar_amount) — Total revenues for nine months ended September 30, 2025
• $103.86 million (dollar_amount) — Net income attributable to common stockholders for nine months ended September 30, 2025
• $130.98 million (dollar_amount) — Acquisitions of real estate properties for nine months ended September 30, 2025
• $81.63 million (dollar_amount) — Cash and cash equivalents as of September 30, 2025
• $1.11 billion (dollar_amount) — Debt, net, as of September 30, 2025
• $346.16 million (dollar_amount) — Proceeds from issuance of senior notes for nine months ended September 30, 2025
• $134.92 million (dollar_amount) — Proceeds from issuance of common shares, net, for nine months ended September 30, 2025

FAQ

Risk Factors

• Interest Rate Fluctuations [medium — financial]: The company's financial results are sensitive to changes in interest rates, which can affect borrowing costs and the valuation of its debt and investments. For the nine months ended September 30, 2025, interest expense was $43.1 million, a slight decrease from $44.7 million in the prior year, indicating some management of this risk.
• Real Estate Market Conditions [high — market]: The value and performance of NHI's real estate portfolio are subject to the broader real estate market conditions, including occupancy rates, rental demand, and property values. The significant increase in real estate acquisitions ($130.98 million in 2025 vs. $9.87 million in 2024) highlights exposure to market dynamics.
• Senior Housing Operating Expenses [medium — operational]: Rising operating expenses in the senior housing sector can impact profitability. These expenses increased to $37.5 million for the nine months ended September 30, 2025, from $31.5 million in the prior year, necessitating careful cost management.
• Healthcare Regulations [medium — regulatory]: As a healthcare-focused REIT, NHI is subject to various federal, state, and local regulations governing healthcare providers and facilities. Changes in these regulations could impact operations and profitability.
• Leverage and Debt Management [high — financial]: While net debt decreased to $1.11 billion from $1.15 billion, the company maintains a significant debt load. The issuance of $346.16 million in senior notes during the period indicates ongoing reliance on debt financing, which carries inherent risks.

Industry Context

National Health Investors Inc. operates within the healthcare real estate investment trust (REIT) sector, focusing on senior housing and medical office buildings. The industry is characterized by an aging demographic driving demand, but also by increasing operating costs, regulatory complexities, and a competitive landscape for acquisitions. Trends include a shift towards more specialized care facilities and the impact of reimbursement policies.

Regulatory Implications

As a healthcare REIT, NHI is subject to evolving healthcare regulations, including those related to patient care, facility standards, and reimbursement models. Compliance with these regulations is critical to maintaining operational stability and avoiding penalties. Changes in healthcare policy could impact the demand for services and the financial health of NHI's tenants.

What Investors Should Do

1. Monitor acquisition strategy effectiveness
2. Analyze debt levels and financing costs
3. Evaluate senior housing operating expense trends
4. Assess cash flow generation from operations

Key Dates

• 2025-09-30: Nine months ended September 30, 2025 — Period of significant revenue growth, net income increase, and aggressive real estate acquisition.
• 2024-09-30: Nine months ended September 30, 2024 — Prior year comparison period showing lower revenues and net income, and significantly less real estate acquisition activity.
• 2025-12-31: As of December 31, 2024 — Balance sheet date for comparison of assets, liabilities, and equity at the beginning of the reporting period.

Glossary

Real estate properties, net

The value of land, buildings, and improvements, net of accumulated depreciation. (Represents the core asset base of NHI, showing a net increase to $2.30 billion, reflecting portfolio growth.)

Mortgage and other notes receivable, net

Loans provided by NHI to operators or other entities, net of allowances for potential credit losses. (Decreased to $209.17 million from $268.93 million, indicating a reduction in outstanding loans.)

Redeemable noncontrolling interest

Represents the equity interest in consolidated entities that is redeemable by the holder, often outside of NHI's control. (A small liability of $9.03 million, indicating limited exposure to these interests.)

Capital in excess of par value

The amount received from the issuance of stock above its par value. (Increased significantly to $1.88 billion from $1.74 billion, reflecting equity financing activities.)

Retained earnings

Accumulated profits of the company that have not been distributed to shareholders as dividends. (Increased to $2.71 billion from $2.60 billion, showing profitable operations over time.)

Noncontrolling interests

The portion of equity in a subsidiary that is not owned by the parent company. (A minor component of total equity, indicating consolidated entities where NHI does not hold full ownership.)

Year-Over-Year Comparison

For the nine months ended September 30, 2025, National Health Investors Inc. demonstrated robust growth compared to the prior year. Total revenues increased by 8.17% to $269.81 million, and net income attributable to common stockholders rose by 9.73% to $103.86 million. Diluted EPS saw a modest increase to $2.22. A significant shift is the aggressive expansion in real estate acquisitions, up from $9.87 million to $130.98 million, alongside a substantial increase in cash and cash equivalents to $81.63 million. Net debt saw a slight reduction to $1.11 billion, and total assets grew to $2.69 billion, reflecting the company's expansionary strategy.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value per share NHI New York Stock

Filing Documents

• nhi-20250930.htm (10-Q) — 2355KB
• exhibit42nhififthsupplemen.htm (EX-4.2) — 46KB
• ex101nhicreditagreementame.htm (EX-10.1) — 1284KB
• ex102nhitermloanamendment.htm (EX-10.2) — 1037KB
• nhi-9302025x10qex311.htm (EX-31.1) — 11KB
• nhi-9302025x10qex312.htm (EX-31.2) — 11KB
• nhi-9302025x10qex32.htm (EX-32) — 8KB
• image_0.jpg (GRAPHIC) — 3KB
• image_1.jpg (GRAPHIC) — 44KB
• 0000877860-25-000183.txt ( ) — 14386KB
• nhi-20250930.xsd (EX-101.SCH) — 89KB
• nhi-20250930_cal.xml (EX-101.CAL) — 87KB
• nhi-20250930_def.xml (EX-101.DEF) — 467KB
• nhi-20250930_lab.xml (EX-101.LAB) — 910KB
• nhi-20250930_pre.xml (EX-101.PRE) — 712KB
• nhi-20250930_htm.xml (XML) — 1774KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 3

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 42

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 73

Controls and Procedures

Item 4. Controls and Procedures 74

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 75

Risk Factors

Item 1A. Risk Factors 75

Other Information

Item 5. Other Information 76

Exhibits

Item 6. Exhibits 77

Signatures

Signatures 78 2 Table of Content

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements NATIONAL HEALTH INVESTORS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) September 30, December 31, 2025 2024 (unaudited) Assets: Real estate properties: Land $ 209,444 $ 191,909 Buildings and improvements 2,882,373 2,751,071 Construction in progress 12,465 10,568 Total real estate properties 3,104,282 2,953,548 Less: Accumulated depreciation ( 801,614 ) ( 742,295 ) Total real estate properties, net 2,302,668 2,211,253 Mortgage and other notes receivable, net of credit loss reserves of $ 15,443 and $ 20,249 , respectively 209,169 268,926 Cash and cash equivalents 81,625 24,289 Straight-line rents receivable 77,906 87,150 Other assets, net 18,696 22,753 Total assets 1 $ 2,690,064 $ 2,614,371 Liabilities and Equity: Liabilities: Debt, net $ 1,109,065 $ 1,146,041 Accounts payable and other liabilities 34,654 37,757 Dividends payable 43,827 41,119 Deferred income 4,020 4,277 Total liabilities 1 1,191,566 1,229,194 Commitments and contingencies Redeemable noncontrolling interest 9,034 9,790 Equity: National Health Investors, Inc. stockholders' equity: Common stock, $ 0.01 par value per share, 100,000,000 shares authorized, 47,638,502 and 45,687,942 shares issued and outstanding, respectively 476 457 Capital in excess of par value 1,875,800 1,736,831 Retained earnings 2,708,843 2,604,829 Cumulative dividends ( 3,104,220 ) ( 2,975,642 ) Total National Health Investors, Inc. stockholders' equity 1,480,899 1,366,475 Noncontrolling interests 8,565 8,912 Total equity 1,489,464 1,375,387 Total liabilities and equity $ 2,690,064 $ 2,614,371 1 The condensed consolidated balance sheets included the following amounts related to our consolidated variable interest entities: $ 400.3 million and $ 505.9 million of real estate properties, net; $ 7.6 million and $ 9.7 million of cash and cash equivalents; $ 0.6 million and $ 10.0 million of straight-line re

View Full Filing

View this 10-Q filing on SEC EDGAR